Skip to main content
. Author manuscript; available in PMC: 2017 Feb 4.
Published in final edited form as: Nature. 2016 Aug 4;536(7614):41–47. doi: 10.1038/nature18642

Extended Data Table 8. Testing for synthetic associations across GWAS-identified T2D loci.

Gene names refer to protein-coding transcript(s) closest to the index SNV. Reported index SNVs are the previously-reported GWAS variants (in European populations) with the strongest association signal in the GoT2D sequencing data (n=2,657). Relative likelihoods are based on causal models with only the chosen low-frequency and rare missense variants, relative to models with only the GWAS index SNV, assessed using the Akaike Information content (AIC) of each regression model, calculated as exp[(AICindex–AIClow-frequency or rare)/2]. n1 provides the number of low-frequency or rare variants required for the residual odds ratio at the GWAS index SNV, after joint conditioning on the low-frequency and rare variants, to switch direction of effect. n2 provides the number of low-frequency or rare variants required for the association p-value remaining at the GWAS index SNV, after joint conditioning on the low-frequency and rare variants, to exceed 0.05.

Index SNV association
signal
Synthetic association by missense
variants
Synthetic association by all low-
frequency and rare variants across 5Mb region

Index SNV
association
signal before
inclusion of
missense variants
Index SNV
association
signal after
inclusion of
missense variants
Index SNV
association
after inclusion of
single
best variant
Testing
groups of low-
frequency
and rare
variants



Gene Index SNV MAF OR
[95%
interval]
p-value Number
Missense
Variants
OR
[95%
interval]
p-value Relative
likelihood
of LF
model
Best LF
Variant
MAF OR
[95%
interval]
p-value n1 n2
TCF7L2 10:114758349 0.27 1.75 [1.54-1.99] 2.80×10−18 6 1.73 [1.52-1.97] 2.33×10−17 1.8×10−17 10:114787948 1.6% 1.72 [1.51-1.95] 1.62×10−16 >50 35
ADCY5 3:123065778 0.19 0.69 [0.60-0.79] 1.12×10−7 13 0.70 [0.61-0.81] 9.00×10−7 9.7×10−8 3:123096056 2.5% 0.71 [0.61-0.82] 3.04×10−6 13 6
IRS1 2:227093745 0.36 0.76 [0.68-0.86] 2.80×10−6 5 0.77 [0.69-0.86] 4.30×10−6 4.5×10−7 2:226993370 1.7% 0.78 [0.70-0.88] 2.19×10−5 12 6
KCNQ1 11:2847069 0.45 0.78 [0.70-0.87] 1.22×10−5 >50 0.84 [0.75-0.94] 2.07×10−3 1.0×10−7 11:2825279 4.7% 0.81 [0.71-0.91] 3.19×10−4 16 6
CDC 123-CAMK1D 10:12307894 0.25 1.33 [1.17-1.52] 1.19×10−5 4 1.30 [1.13-1.50] 2.06×10−4 7.1×10−5 10:12325477 3.8% 1.29 [1.12-1.48] 3.03×10−4 10 5
CDKN2A-CDKN2B 9:22137685 0.28 1.28 [1.14-1.45] 4.52×10−5 4 1.27 [1.13-1.43] 9.28×10−5 4.3×10−5 9:22133773 3.5% 1.25 [1.10-1.41] 5.98×10−4 22 7
IGF2BP2 3:185511687 0.32 1.25 [1.11-1.41] 1.65×10−4 14 1.21 [1.07-1.36] 2.12×10−3 3.0×10−4 3:185550500 4.1% 1.20 [1.07-1.36] 2.91×10−3 8 3
KLHDC5 12:27965150 0.17 0.76 [0.66-0.88] 2.19×10−4 3 0.77 [0.66-0.89] 4.45×10−4 1.2×10−3 12:27832062 2.0% 0.80 [0.68-0.92] 3.04×10−3 10 4
SLC30A8 8:118184783 0.33 0.81 [0.72-0.91] 2.95×10−4 2 0.81 [0.72-0.91] 3.73×10−4 0.02 8:117964024 2.2% 0.83 [0.73-0.93] 1.23×10−3 17 6
CDKAL1 6:20694884 0.18 1.28 [1.11-1.48] 6.05×10−4 1 1.28 [1.11-1.48] 7.57×10−4 0.007 6:20718780 2.8% 1.23 [1.06-1.43] 7.71×10−3 9 3